open access

Online first
Short communication
Published online: 2023-02-11
Get Citation

Evaluation of microdamage to the central nervous system, expressed by an increase in plasma concentration of specific neuronal enolase in the course of vasovagal syncope

Joanna Jędrzejczyk-Spaho
DOI: 10.33963/KP.a2023.0042

open access

Online first
Short communication
Published online: 2023-02-11

Abstract

Not available

Abstract

Not available
Get Citation
Supp./Additional Files (1)
Supplementary material
Download
129KB
About this article
Title

Evaluation of microdamage to the central nervous system, expressed by an increase in plasma concentration of specific neuronal enolase in the course of vasovagal syncope

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2023-02-11

Page views

44

Article views/downloads

31

DOI

10.33963/KP.a2023.0042

Authors

Joanna Jędrzejczyk-Spaho

References (14)
  1. Ishida K, Gohara T, Kawata R, et al. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery? J Cardiothorac Vasc Anesth. 2003; 17(1): 4–9.
  2. Ryczek R, Kwasiborski PJ, Dymus J, et al. Neuron-specific enolase concentrations for the prediction of poor prognosis of comatose patients after out-of-hospital cardiac arrest: an observational cohort study. Kardiol Pol. 2021; 79(5): 546–553.
  3. Lee SY, Choi YC, Kim JH, et al. Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope. J Neurol. 2010; 257(10): 1708–1712.
  4. Bartoletti A, Alboni P, Ammirati F, et al. 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace. 2000; 2(4): 339–342.
  5. Sutton R, Benditt D, Brignole M, et al. Syncope: diagnosis and management according to the 2009 guidelines of the European Society of Cardiology. Pol Arch Intern Med . 2010; 120(1-2): 42–48.
  6. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation. 2000; 102(3): 294–299.
  7. http://zsi.tech.us.edu.pl/~nowak/odzw/korelacje.pdf.
  8. Chu W, Wang C, Lin P, et al. Transient aphasia: a rare complication of head-up tilt test. Neurological Sciences. 2014; 35(7): 1127–1132.
  9. Ryan DJ, Harbison JA, Meaney JF, et al. Syncope causes transient focal neurological symptoms. QJM. 2015; 108(9): 711–718.
  10. Ishida K, Gohara T, Kawata R, et al. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery? J Cardiothorac Vasc Anesth. 2003; 17(1): 4–9.
  11. Dave KR, Raval AP, Prado R, et al. Mild cardiopulmonary arrest promotes synaptic dysfunction in rat hippocampus. Brain Res. 2004; 1024(1-2): 89–96.
  12. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993; 361(6407): 31–39.
  13. Lee SY, Choi YC, Kim JH, et al. Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope. J Neurol. 2010; 257(10): 1708–1712.
  14. Elmståhl S, Widerström E. Orthostatic intolerance predicts mild cognitive impairment: incidence of mild cognitive impairment and dementia from the Swedish general population cohort Good Aging in Skåne. Clin Interv Aging. 2014; 9: 1993–2002.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl